Position paper presented at CSIMS 2024 by Hon. Robert G. Rassp, Chairman of the Board of Directors, Friends Research Institute (friendsresearch.org) Disclaimers: The opinions expressed in this article...
CALIFORNIA COMPENSATION CASES Vol. 89, No. 8 August 2024 A Report of En Banc and Significant Panel Decisions of the WCAB and Selected Court Opinions of Related Interest, With a Digest of WCAB Decisions...
By Hon. Susan V. Hamilton, Former Assistant Secretary and Deputy Commissioner, California Workers’ Compensation Appeals Board The June 13, 2024 edition of the LexisNexis Workers’ Compensation...
LexisNexis has selected some of the top “noteworthy” panel decisions issued by the California Workers’ Compensation Appeals Board during the period January through June 2024. The first...
By Hon. Susan V. Hamilton, Former Assistant Secretary and Deputy Commissioner, California Workers’ Compensation Appeals Board It is well understood that the California Insurance Guarantee Association...
A Pennsylvania appellate court held that a compromise and release (C&R) agreement may not be employed to avoid the procedures in the state’s Workers’ Compensation Act for challenging a provider's invoice or a fee review determination that the invoice must be paid. That is because the parties to a C&R agreement can bind each other; they cannot release themselves from liability to a person or entity who is not a party. Thus, where claimant and the insurer entered into a C&R agreement that provided for payment of all “reasonable, necessary and related medical expenses incurred before the hearing date,” and further provided that no benefits would be paid for any compounded prescription cream, the insurer could not refuse to pay a pharmacy $6,644.30, plus interest, for a compound prescription cream that was prescribed prior to the hearing date on the C&R agreement. The court noted that one year earlier, the insurer had sought utilization review regarding the identical compound cream and the utilization review organization determined that the cream prescribed to Claimant was reasonable and necessary to treat Claimant's accepted work injury. To the extent the insurer desired to challenge the treatment as neither reasonable nor necessary, it had to see UR under the Act.
Thomas A. Robinson, J.D., the Feature National Columnist for the LexisNexis Workers’ Compensation eNewsletter, is co-author of Larson’s Workers’ Compensation Law (LexisNexis).
LexisNexis Online Subscribers: Citations below link to Lexis Advance.
See Armour Pharmacy v. Bureau of Workers' Comp. Fee Review Hearing Office (National Fire Insurance Company of Hartford), 2018 Pa. Commw. LEXIS 368 (Aug. 7, 2018)
See generally Larson’s Workers’ Compensation Law, § 94.02.
Source: Larson’s Workers’ Compensation Law, the nation’s leading authority on workers’ compensation law